Enter your search term below:
In this issue, Dr. Janet Macpherson, senior co-editor of the Telegraft, reflects on developments in the cell and gene therapy space, and shares her perspective on the connection between these developments and the global ISCT community. #28.2 #28.2 #CareerAndCommunity
[Telegraft 28.2] - From the Editors - April 2021.pdf
FACT Report from April 2021 #28.2 #StakeholderUpdates
[Telegraft 28.2] - FACT Update-V2 - April 2021.pdf
Building on the first ISCT Job Market Survey conducted in 2019, ISCT joined forces with CellCAN to develop a concise survey that aimed to increase response rates from early-stage professionals, primarily in North America. Read about preliminary findings in preparation for the 2021 installment of...
[Telegraft 28.2] - ESP Article - April 2021.pdf
Zlatibor Velickovic, PhD summarises his highlights from the first-ever virtual 2021 ANZ Region Meeting. These highlights include advancements in CAR T-cell therapies as well as reports from gene therapy clinical trials. #28.2 #TranslationalScience
[Telegraft 28.2] - ANZ Regional 2021.pdf
Australia and New Zealand Legal and Regulatory Affairs Watchdog - April 2021 #28.2 #Regulatory #RegulatoryWatchdog
[Telegraft 28.2] - ANZ LRA.pdf
PACT Update from April 2021 #28.2 #StakeholderUpdates
[Telegraft 28,2] - PACT Update - V2.pdf